OTC — Ocumetics Technology Income Statement
0.000.00%
Last trade - 00:00
- CA$38.92m
- CA$38.69m
2020 July 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 5 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Total Operating Expenses | 0.172 | 0.894 | 2.22 | 3.64 |
Operating Profit | -0.172 | -0.894 | -2.22 | -3.64 |
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -0.172 | -1.46 | -2.22 | -3.64 |
Net Income After Taxes | -0.172 | -1.46 | -2.22 | -3.64 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.172 | -1.46 | -2.22 | -3.64 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.172 | -1.46 | -2.22 | -3.64 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.002 | -0.014 | -0.02 | -0.032 |
Dividends per Share |